Lord Drayson inaugurates new Oxford Nanopore facility at The Oxford Science Park

10-Jul-2009 - Oxford Nanopore Technology’s new building was officially opened by Science and Innovation Minister Lord Drayson. The Science Minister visited the new home for the Oxford-based technology company at the Oxford Science Park. The company, founded in 2005, now employs 60 people and its new home will ...

SCHOTT to strengthen its presence in South America

Acquisition of the pharmaceutical packaging business from Medical Glass and DIESCA in Argentina

09-Jul-2009 - SCHOTT Pharmaceutical Packaging has strengthened its presence in South America by taking over the business from Medical Glass S.A. as well as DIESCA S.A. Effective immediately, both companies will begin trading under the new name SCHOTT Envases Argentina S.A. The acquisition of the packaging ...

Cangene acquires Twinstrand Therapeutics Inc.

09-Jul-2009 - Cangene Corporation announces that it has acquired all issued and outstanding shares of privately held Twinstrand Therapeutics Inc. Cangene has paid $1.5 million (subject to post-closing adjustments) to acquire Twinstrand which has products, technologies and financial attributes including those ...

Increased yields through better CO2 use in plants

BASF Plant Science and the University of Cologne cooperate in plant biotechnology

09-Jul-2009 - BASF Plant Science and the Botanical Institute of the University of Cologne announce that they have entered a cooperation in plant biotechnology. Focus is on plant traits that increase the yield of crops like soybeans, rice, and canola and improve their tolerance to adverse environmental ...

ART Receives $500,000 From Government of Canada to Pursue Commercialization Activities in North America

09-Jul-2009 - ART Advanced Research Technologies Inc. reported that it has been awarded $500,000 in repayable funding by the Government of Canada for the commercialization of its Optix® MX3 and SoftScan® optical molecular imaging products in North America. The Honourable Christian Paradis, Minister of Public ...

Frost & Sullivan Identifies Innovative and Cost-effective Technology as Key Competitive Factor in European Medical Device Market

08-Jul-2009 - The medical device industry is one of the most vital and dynamic sectors of the European economy. The industry is constantly driven by R&D, which needs to keep pace with the evolving demands of the medical fraternity. New analysis from Frost & Sullivan, European Medical Device Company Profiles, ...

Millipore and Proteome Sciences Announce Licensing Agreement

08-Jul-2009 - Millipore Corporation and Proteome Sciences plc announced they have signed an exclusive license agreement to develop new products that will help to advance the study of Alzheimer’s disease. Under the terms of the agreement, Millipore will develop Luminex bead-based multiplex immunoassays to ...

Evotec-RSIL Ltd extends library synthesis collaboration with Ferrer Grupo

08-Jul-2009 - Evotec-RSIL Ltd. announced that Ferrer Grupo has extended their ongoing collaboration. The two year extension is the third agreement between Ferrer Grupo and Evotec-RSIL in the last year and is based on the excellent results achieved by Evotec-RSIL in generating libraries on schedule and to the ...

Actelion Chooses GENEART as Exclusive Supplier for DNA Engineering & Processing Services

Framework agreement with Actelion Pharmaceuticals Ltd. signed

08-Jul-2009 - GENEART AG announces the signing of a framework agreement with the Swiss company Actelion Pharmaceuticals Ltd. Within the scope of this agreement, Actelion will receive system solutions for DNA engineering & processing (gene optimization, gene synthesis and plasmid preparation) exclusively from ...

Santhera Aligns Resources and Plans to Restructure Drug Discovery

08-Jul-2009 - Santhera Pharmaceuticals announced that it plans to focus the organization on preclinical and clinical development as well as commercialization of small molecules in rare neuromuscular disorders and related attractive niche indications. As a consequence, the Company intends to reduce headcount ...